SCHEMBL8832095

SCHEMBL8832095

COC(=O)c1cccc2nc3c(nc12)c1ccccc1n3C

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 5/20 0.52
▸ KDM4E B2RXH2 4/20 0.52
▸ GAA P10253 1/20 0.52
▸ ATM Q13315 1/20 0.52
▸ L3MBTL1 Q9Y468 2/20 0.49
▸ LMNA P02545 2/20 0.49
▸ NPC1 O15118 1/20 0.47
▸ RAB9A P51151 1/20 0.47
▸ GABRP O00591 3/20 0.46
▸ GABRD O14764 3/20 0.46
▸ GABRA1 P14867 3/20 0.46
▸ GABRB1 P18505 3/20 0.46
▸ GABRG2 P18507 3/20 0.46
▸ GABRB3 P28472 3/20 0.46
▸ GABRA5 P31644 3/20 0.46
▸ GABRA3 P34903 3/20 0.46
▸ GABRA2 P47869 3/20 0.46
▸ GABRB2 P47870 3/20 0.46
▸ GABRA4 P48169 3/20 0.46
▸ GABRE P78334 3/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8832241 0.96 KMT2A (0.53) KMT2AKDM4EGAAATML3MBTL1
SCHEMBL8831926 0.81 KMT2A (0.58) KMT2AKDM4EGAAATML3MBTL1
SCHEMBL71209 0.80 KDM4E (0.74) KMT2AKDM4EGAAATMLMNA
SCHEMBL13653391 0.78 KMT2A (0.68) KMT2AKDM4EGAAATMLMNA
SCHEMBL16621922 0.77 MEN1 (0.68) KMT2AKDM4EGAAATML3MBTL1
SCHEMBL8832299 0.76 L3MBTL1 (0.54) KMT2AKDM4EGAAATML3MBTL1
SCHEMBL5886447 0.76 KMT2A (0.54) KMT2AKDM4EGAAATMMAPT
SCHEMBL24272528 0.74 MAPT (0.56) KMT2AKDM4EGAAL3MBTL1LMNA
SCHEMBL8831999 0.74 L3MBTL1 (0.50) KMT2AKDM4EGAAATML3MBTL1
SCHEMBL30149921 0.74 KMT2A (0.67) KMT2AKDM4EGAAATMLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5597921-A ANTITUMOR AGENTS, TREATMENT OF LEUKEMIA TAISHO PHARMACEUTICAL CO., LTD. (JP) 1997-01-28 — — US disclosed
EP-0695754-A1 INDOLO 2,3-b]QUINOXALINE DERIVATIVE TAISHO PHARMACEUTICAL CO. LTD (JP) 1996-02-07 — — EP disclosed
Send feedback